Compile Data Set for Download or QSAR
maximum 50k data
Found 26 Enz. Inhib. hit(s) with all data for entry = 10882
TargetOrexin receptor type 2(Homo sapiens (Human))
Merck Sharp &Amp

WIPO
LigandPNGBDBM576194(WO2022094012, Example 1A)
Affinity DataEC50:  1.06E+3nMAssay Description: In a typical experiment, the OX1 and OX2 receptor agonist activity is determined in accordance with the following general experimental method. Chine...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails PubMed
TargetOrexin receptor type 2(Homo sapiens (Human))
Merck Sharp &Amp

WIPO
LigandPNGBDBM576219(WO2022094012, Example 21B)
Affinity DataEC50:  0.5nMAssay Description: In a typical experiment, the OX1 and OX2 receptor agonist activity is determined in accordance with the following general experimental method. Chine...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails PubMed
TargetOrexin receptor type 2(Homo sapiens (Human))
Merck Sharp &Amp

WIPO
LigandPNGBDBM576196(WO2022094012, Example 2)
Affinity DataEC50:  813nMAssay Description: In a typical experiment, the OX1 and OX2 receptor agonist activity is determined in accordance with the following general experimental method. Chine...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails PubMed
TargetOrexin receptor type 2(Homo sapiens (Human))
Merck Sharp &Amp

WIPO
LigandPNGBDBM576197(WO2022094012, Example 3)
Affinity DataEC50:  2.50E+3nMAssay Description: In a typical experiment, the OX1 and OX2 receptor agonist activity is determined in accordance with the following general experimental method. Chine...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails PubMed
TargetOrexin receptor type 2(Homo sapiens (Human))
Merck Sharp &Amp

WIPO
LigandPNGBDBM576198(WO2022094012, Example 4)
Affinity DataEC50:  3.84E+3nMAssay Description: In a typical experiment, the OX1 and OX2 receptor agonist activity is determined in accordance with the following general experimental method. Chine...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails PubMed
TargetOrexin receptor type 2(Homo sapiens (Human))
Merck Sharp &Amp

WIPO
LigandPNGBDBM576199(WO2022094012, Example 5)
Affinity DataEC50:  1.38E+3nMAssay Description: In a typical experiment, the OX1 and OX2 receptor agonist activity is determined in accordance with the following general experimental method. Chine...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails PubMed
TargetOrexin receptor type 2(Homo sapiens (Human))
Merck Sharp &Amp

WIPO
LigandPNGBDBM576200(WO2022094012, Example 6A)
Affinity DataEC50:  12nMAssay Description: In a typical experiment, the OX1 and OX2 receptor agonist activity is determined in accordance with the following general experimental method. Chine...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails PubMed
TargetOrexin receptor type 2(Homo sapiens (Human))
Merck Sharp &Amp

WIPO
LigandPNGBDBM576201(WO2022094012, Example 6B)
Affinity DataEC50:  0.600nMAssay Description: In a typical experiment, the OX1 and OX2 receptor agonist activity is determined in accordance with the following general experimental method. Chine...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails PubMed
TargetOrexin receptor type 2(Homo sapiens (Human))
Merck Sharp &Amp

WIPO
LigandPNGBDBM576202(WO2022094012, Example 7)
Affinity DataEC50:  4.60nMAssay Description: In a typical experiment, the OX1 and OX2 receptor agonist activity is determined in accordance with the following general experimental method. Chine...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails PubMed
TargetOrexin receptor type 2(Homo sapiens (Human))
Merck Sharp &Amp

WIPO
LigandPNGBDBM576203(WO2022094012, Example 8)
Affinity DataEC50:  14nMAssay Description: In a typical experiment, the OX1 and OX2 receptor agonist activity is determined in accordance with the following general experimental method. Chine...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails PubMed
TargetOrexin receptor type 2(Homo sapiens (Human))
Merck Sharp &Amp

WIPO
LigandPNGBDBM576204(WO2022094012, Example 9A)
Affinity DataEC50:  416nMAssay Description: In a typical experiment, the OX1 and OX2 receptor agonist activity is determined in accordance with the following general experimental method. Chine...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails PubMed
TargetOrexin receptor type 2(Homo sapiens (Human))
Merck Sharp &Amp

WIPO
LigandPNGBDBM576205(WO2022094012, Example 9B)
Affinity DataEC50:  6nMAssay Description: In a typical experiment, the OX1 and OX2 receptor agonist activity is determined in accordance with the following general experimental method. Chine...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails PubMed
TargetOrexin receptor type 2(Homo sapiens (Human))
Merck Sharp &Amp

WIPO
LigandPNGBDBM576206((R,E)-4-ethyl-3-methyl-13-oxa-4,6,9-triaza-1(6,8)-...)
Affinity DataEC50:  950nMAssay Description: In a typical experiment, the OX1 and OX2 receptor agonist activity is determined in accordance with the following general experimental method. Chine...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails PubMed
TargetOrexin receptor type 2(Homo sapiens (Human))
Merck Sharp &Amp

WIPO
LigandPNGBDBM576207(WO2022094012, Example 11)
Affinity DataEC50:  778nMAssay Description: In a typical experiment, the OX1 and OX2 receptor agonist activity is determined in accordance with the following general experimental method. Chine...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails PubMed
TargetOrexin receptor type 2(Homo sapiens (Human))
Merck Sharp &Amp

WIPO
LigandPNGBDBM576208(WO2022094012, Example 12)
Affinity DataEC50:  20nMAssay Description: In a typical experiment, the OX1 and OX2 receptor agonist activity is determined in accordance with the following general experimental method. Chine...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails PubMed
TargetOrexin receptor type 2(Homo sapiens (Human))
Merck Sharp &Amp

WIPO
LigandPNGBDBM576209(WO2022094012, Example 13)
Affinity DataEC50:  634nMAssay Description: In a typical experiment, the OX1 and OX2 receptor agonist activity is determined in accordance with the following general experimental method. Chine...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails PubMed
TargetOrexin receptor type 2(Homo sapiens (Human))
Merck Sharp &Amp

WIPO
LigandPNGBDBM576210(WO2022094012, Example 14)
Affinity DataEC50:  9.70nMAssay Description: In a typical experiment, the OX1 and OX2 receptor agonist activity is determined in accordance with the following general experimental method. Chine...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails PubMed
TargetOrexin receptor type 2(Homo sapiens (Human))
Merck Sharp &Amp

WIPO
LigandPNGBDBM576211(WO2022094012, Example 15)
Affinity DataEC50:  1.18E+3nMAssay Description: In a typical experiment, the OX1 and OX2 receptor agonist activity is determined in accordance with the following general experimental method. Chine...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails PubMed
TargetOrexin receptor type 2(Homo sapiens (Human))
Merck Sharp &Amp

WIPO
LigandPNGBDBM576212(WO2022094012, Example 16)
Affinity DataEC50:  3.88E+3nMAssay Description: In a typical experiment, the OX1 and OX2 receptor agonist activity is determined in accordance with the following general experimental method. Chine...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails PubMed
TargetOrexin receptor type 2(Homo sapiens (Human))
Merck Sharp &Amp

WIPO
LigandPNGBDBM576213(WO2022094012, Example 17)
Affinity DataEC50:  19nMAssay Description: In a typical experiment, the OX1 and OX2 receptor agonist activity is determined in accordance with the following general experimental method. Chine...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails PubMed
TargetOrexin receptor type 2(Homo sapiens (Human))
Merck Sharp &Amp

WIPO
LigandPNGBDBM576214(WO2022094012, Example 18)
Affinity DataEC50:  27nMAssay Description: In a typical experiment, the OX1 and OX2 receptor agonist activity is determined in accordance with the following general experimental method. Chine...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails PubMed
TargetOrexin receptor type 2(Homo sapiens (Human))
Merck Sharp &Amp

WIPO
LigandPNGBDBM576215(WO2022094012, Example 19A)
Affinity DataEC50:  337nMAssay Description: In a typical experiment, the OX1 and OX2 receptor agonist activity is determined in accordance with the following general experimental method. Chine...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails PubMed
TargetOrexin receptor type 2(Homo sapiens (Human))
Merck Sharp &Amp

WIPO
LigandPNGBDBM576216(WO2022094012, Example 19B)
Affinity DataEC50:  6.60nMAssay Description: In a typical experiment, the OX1 and OX2 receptor agonist activity is determined in accordance with the following general experimental method. Chine...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails PubMed
TargetOrexin receptor type 2(Homo sapiens (Human))
Merck Sharp &Amp

WIPO
LigandPNGBDBM576217(WO2022094012, Example 20)
Affinity DataEC50:  9.5nMAssay Description: In a typical experiment, the OX1 and OX2 receptor agonist activity is determined in accordance with the following general experimental method. Chine...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails PubMed
TargetOrexin receptor type 2(Homo sapiens (Human))
Merck Sharp &Amp

WIPO
LigandPNGBDBM576218(WO2022094012, Example 21A)
Affinity DataEC50:  20nMAssay Description: In a typical experiment, the OX1 and OX2 receptor agonist activity is determined in accordance with the following general experimental method. Chine...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails PubMed
TargetOrexin receptor type 2(Homo sapiens (Human))
Merck Sharp &Amp

WIPO
LigandPNGBDBM576195(WO2022094012, Example 1B)
Affinity DataEC50:  126nMAssay Description: In a typical experiment, the OX1 and OX2 receptor agonist activity is determined in accordance with the following general experimental method. Chine...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails PubMed